Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling considerations

References

• van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet. 2016; 48:1043–1048.
   PubMed Web of Science ®Google Scholar
• Guerreiro RJ, Lohmann E, Bras JM, Gibbs JR, Rohrer JD, Gurunlian N, et al. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. JAMA Neurol. 2013;70:78–84.
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
   PubMed Web of Science ®Google Scholar
• Gibson SB, Figueroa KP, Bromberg MB, Pulst S-M, Cannon-Albright L. Familial clustering of ALS in a population-based resource. Neurology. 2014;82:17–22.
   PubMed Web of Science ®Google Scholar
• Fong KY, Yu YL, Chan YW, Kay R, Chan J, Yang Z, et al. Motor Neuron Disease in Hong Kong Chinese: Epidemiology and Clinical Picture. Neuroepidemiology. 1996;15:239–45.
   PubMed Web of Science ®Google Scholar
• Haberlandt WF. Genetic aspects of amyotrophic lateral sclerosis and progressive bulbar paralysis. Acta Genet Med Gemel. 1959;8:369–374.
   Google Scholar
• Seelaar H, Kamphorst W, Rosso SM, Azmani A, Masdjedi R, de Koning I, et al. Distinct genetic forms of frontotemporal dementia. Neurology 2008;71:1220–6.
   PubMed Web of Science ®Google Scholar
• Rosso SM, Kaat LD, Baks T, Joosse M, de Koning I, Pijnenburg Y, et al. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population‐based study. Brain. 2003;126:2016–22.
   PubMed Web of Science ®Google Scholar
• Sieben A, Van Langenhove T, Engelborghs S, Martin JJ, Boon P, Cras P, et al. The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol. 2012;124:353–72.
   PubMed Web of Science ®Google Scholar
• Cady J, Allred P, Bali T, Pestronk A, Goate A, Miller TM, et al. Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes. Ann Neurol. 2015;77:100–13.
   PubMed Web of Science ®Google Scholar
• Po K, Leslie FVC, Gracia N, Bartley L, Kwok JBJ, Halliday GM, et al. Heritability in frontotemporal dementia: more missing pieces? J Neurol. 2014;261:2170–7.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol. 2011;7:603–15.
   PubMed Web of Science ®Google Scholar
• Calvo A, Moglia C, Canosa A, Brunetti M, Barberis M, Traynor BJ, et al. A de novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case. Neurobiol Aging. 2014;35:1513. e7–e11.
   Web of Science ®Google Scholar
• Armon C. The underestimation of familial ALS and counseling patients with sporadic ALS. Neurology. 2014;82:13–4.
   PubMed Web of Science ®Google Scholar
• Smith BN, Newhouse S, Shatunov A, Vance C, Topp S, Johnson L, et al. The C9ORF72 expansion mutation is a common cause of ALS +/− FTD in Europe and has a single founder. Eur J Hum Genet. 2013;21:102–8.
   PubMed Web of Science ®Google Scholar
• Dobson-Stone C, Hallupp M, Loy CT, Thompson EM, Haan E, Sue CM, et al. C9ORF72 repeat expansion in Australian and Spanish frontotemporal dementia patients. PloS One. 2013;8:e56899.
   PubMed Web of Science ®Google Scholar
• McCann EP, Williams KL, Fifita JA, Tarr IS, O'Connor J, Rowe DB, et al. The genotype-phenotype landscape of familial amyotrophic lateral sclerosis in Australia. Clin Genet. 2017. [Epub ahead of print]. doi: 10.1111/cge.12973
   PubMed Web of Science ®Google Scholar
• Eisen A, Mezei MM, Stewart HG, Fabros M, Gibson G, Andersen PM. SOD1 gene mutations in ALS patients from British Columbia, Canada: Clinical features, neurophysiology and ethical issues in management. Amyotroph Lateral Scler. 2008;9:108–19.
   PubMed Web of Science ®Google Scholar
• Wood EM, Falcone D, Suh E, Irwin DJ, Chen-Plotkin AS, Lee EB, et al. Development and validation of pedigree classification criteria for frontotemporal lobar degeneration. JAMA Neurol. 2013;70:1411.
   PubMed Web of Science ®Google Scholar
• Byrne S, Bede P, Elamin M, Kenna K, Lynch C, McLaughlin R, et al. Proposed criteria for familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:157–9.
   PubMed Web of Science ®Google Scholar
• Byrne S, Elamin M, Bede P, Hardiman O. Absence of consensus in diagnostic criteria for familial neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 2012;83:365–7.
   PubMed Web of Science ®Google Scholar
• Wagner KN, Nagaraja H, Allain DC, Quick A, Kolb S, Roggenbuck J. Patients with Amyotrophic Lateral Sclerosis Have High Interest in and Limited Access to Genetic Testing. J Genet Couns. 2017;26:604–11.
   PubMed Web of Science ®Google Scholar
• Cunningham J, Goldsmith L, Skirton H. The evidence base regarding the experiences of and attitudes to preimplantation genetic diagnosis in prospective parents. Midwifery 2015;31:288–96.
   PubMed Web of Science ®Google Scholar
• Arthur KC, Doyle C, Chio A, Traynor BJ. Use of Genetic Testing in Amyotrophic Lateral Sclerosis by Neurologists. JAMA Neurol. 2017;74:125–6.
   PubMed Web of Science ®Google Scholar
• van Es MA, Dahlberg C, Birve A, Veldink JH, van den Berg LH, Andersen PM. Large-scale SOD1 mutation screening provides evidence for genetic heterogeneity in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2010;81:562–6.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, et al. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol. 2005;12:921–38.
   PubMed Web of Science ®Google Scholar
• Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, et al. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol. 2007;14:e1–e26.
   PubMed Web of Science ®Google Scholar
• Cohn-Hokke PE, Elting MW, Pijnenburg YA, van Swieten JC. Genetics of dementia: Update and guidelines for the clinician. Am J Med Genet Part B Neuropsychiatr Genet. 2012;159 B:628–43.
   Web of Science ®Google Scholar
• Chiò A, Battistini S, Calvo A, Caponnetto C, Conforti FL, Corbo M, et al. Genetic counselling in ALS: Facts, uncertainties and clinical suggestions. J Neurol Neurosurg Psychiatry. 2014;85:478–85.
   PubMed Web of Science ®Google Scholar
• Lindquist S, Dunø M, Svenstrup K, Nielsen J. [Genetic counselling is relevant in familial as well as sporadic cases of amyotrophic lateral sclerosis]. Ugeskr Laeger. 2014;176:2457–60.
   Google Scholar
• Roggenbuck J, Quick A, Kolb SJ, Genetic testing and genetic counseling for amyotrophic lateral sclerosis: an update for clinicians. Genet Med. 2016;advance online publication.
   Google Scholar
• Arthur KC, Calvo A, Price TR, Geiger JT, Chio A, Traynor BJ. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun. 2016;7:12408.
   PubMed Web of Science ®Google Scholar
• Bucchia M, Ramirez A, Parente V, Simone C, Nizzardo M, Magri F, et al. Therapeutic Development in Amyotrophic Lateral Sclerosis. Clin Ther. 2015;37:668–80.
   PubMed Web of Science ®Google Scholar
• Jiang J, Zhu Q, Gendron TF, Saberi S, McAlonis-Downes M, Seelman A, et al. Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs. Neuron. 2016;90:535–50.
   PubMed Web of Science ®Google Scholar
• Miller TM, Pestronk A, David W, Rothstein J, Simpson E, Appel SH, et al. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol. 2013;12:435–42.
   PubMed Web of Science ®Google Scholar
• Human Genetics Society of Australasia. Guideline: Pre-symptomatic and predictive testing for genetic disorders. Australia: Human Genetics Society of Australasia; 2014. Contract No.: 2014GD02.
   Google Scholar
• MacLeod R, Tibben A, Frontali M, Evers-Kiebooms G, Jones A, Martinez-Descales A, et al. Recommendations for the predictive genetic test in Huntington's disease. Clin Genet. 2013;83:221–31.
   PubMed Web of Science ®Google Scholar
• Fanos JH, Gronka S, Wuu J, Stanislaw C, Andersen PM, Benatar M. Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis. Genet Med. 2011;13:342–8.
   PubMed Web of Science ®Google Scholar
• Wedderburn S, Panegyres PK, Andrew S, Goldblatt J, Liebeck T, McGrath F, et al. Predictive gene testing for Huntington disease and other neurodegenerative disorders. Intern Med J. 2013;43:1272–9.
   PubMed Web of Science ®Google Scholar
• Sorbi S, Hort J, Erkinjuntti T, Fladby T, Gainotti G, Gurvit H, et al. EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol. 2012;19:1159–79.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, et al. Good practice in the management of amyotrophic lateral sclerosis: Clinical guidelines. An evidence‐based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler. 2007;8:195–213.
   PubMed Web of Science ®Google Scholar
• Bocchetta M, Mega A, Bernardi L, Di Maria E, Benussi L, Binetti G, et al. Genetic Counseling and Testing for Alzheimer’s Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol. J Alzheimers Dis. 2016;51:277–91.
   PubMed Web of Science ®Google Scholar
• Benatar CM, Stanislaw DC, Reyes ME, Hussain MS, Cooley MA, Fernandez MM, et al. Presymptomatic ALS genetic counseling and testing: Experience and recommendations. Neurology. 2016;86:2295–302.
   PubMed Web of Science ®Google Scholar
• Skirton H, Goldsmith L, Jackson L, Tibben A. Quality in genetic counselling for presymptomatic testing - clinical guidelines for practice across the range of genetic conditions. Eur J Hum Genet. 2013;21:256–60.
   PubMed Web of Science ®Google Scholar
• Goldman JS. Genetic testing and counseling in the diagnosis and management of young-onset dementias. Psychiatr Clin North Am. 2015;38:295–308.
   PubMed Web of Science ®Google Scholar
• Guimaraes L, Sequeiros J, Skirton H, Paneque M. What counts as effective genetic counselling for presymptomatic testing in late-onset disorders? A study of the consultand's perspective. J Genet Couns. 2013;22:437–47.
   PubMed Web of Science ®Google Scholar
• Akimoto C, Volk AE, van Blitterswijk M, Van den Broeck M, Leblond CS, Lumbroso S, et al. A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories. J Med Genet. 2014;51:419–24.
   PubMed Web of Science ®Google Scholar
• Molinuevo JL, Pintor L, Peri JM, Lleo A, Oliva R, Marcos T, et al. Emotional reactions to predictive testing in Alzheimer's disease and other inherited dementias. Am J Alzheimers Dis Other Demen. 2005;20:233–8.
   PubMedGoogle Scholar
• Hartzfeld DE, Siddique N, Victorson D, O'Neill S, Kinsley L, Siddique T. Reproductive decision-making among individuals at risk for familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:114–9.
   PubMed Web of Science ®Google Scholar
• Goldman JS, Farmer JM, Van Deerlin VM, Wilhelmsen KC, Miller BL, Grossman M. Frontotemporal dementia: genetics and genetic counseling dilemmas. Neurologist. 2004;10:227–34.
   PubMed Web of Science ®Google Scholar
• van Blitterswijk M, van Es MA, Hennekam EA, Dooijes D, van Rheenen W, Medic J, et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21:3776–84.
   PubMed Web of Science ®Google Scholar
• Snowden JS, Adams J, Harris J, Thompson JC, Rollinson S, Richardson A, et al. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:497–505.
   PubMed Web of Science ®Google Scholar
• Snowden JS, Gibbons ZC, Blackshaw A, Doubleday E, Thompson J, Craufurd D, et al. Social cognition in frontotemporal dementia and Huntington's disease. Neuropsychologia. 2003;41:688–701.
   PubMed Web of Science ®Google Scholar
• Riedijk SR, Niermeijer MFN, Dooijes D, Tibben A. A decade of genetic counseling in frontotemporal dementia affected families: Few counseling requests and much familial opposition to testing. J Genet Couns. 2009;18:350–6.
   PubMed Web of Science ®Google Scholar
• Benatar M, Wuu J. Presymptomatic studies in ALS: Rationale, challenges, and approach. Neurology. 2012;79:1732–9.
   PubMed Web of Science ®Google Scholar
• Fanos JH, Gelinas DF, Miller RG. “You have shown me my end: attitudes toward presymptomatic testing for familial amyotrophic lateral sclerosis”. Am J Med Genet A. 2004;129A:248–53.
   PubMed Web of Science ®Google Scholar
• Steinbart EJ, Smith CO, Poorkaj P, Bird TD. Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia. Arch Neurol. 2001;58:1828–31.
   PubMedGoogle Scholar
• McRae CA, Diem G, Yamazaki TG, Mitek A, Wszolek ZK. Interest in genetic testing in pallido-ponto-nigral degeneration (PPND): a family with frontotemporal dementia with Parkinsonism linked to chromosome 17. Eur J Neurol. 2001;8:179–83.
   PubMed Web of Science ®Google Scholar
• Surampalli A, Khare M, Kubrussi G, Wencel M, Tanaja J, Donkervoort S, et al. Psychological impact of predictive genetic testing in VCP inclusion body myopathy, paget disease of bone and frontotemporal dementia. J Genet Couns. 2015;24:842–50.
   PubMed Web of Science ®Google Scholar
• Paulsen JS, Nance M, Kim JI, Carlozzi NE, Panegyres PK, Erwin C, et al. A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases. Prog Neurobiol. 2013;110:2–28.
   PubMed Web of Science ®Google Scholar
• Morrison PJ, Harding-Lester S, Bradley A. Uptake of Huntington disease predictive testing in a complete population. Clin Genet. 2011;80:281–6.
   PubMed Web of Science ®Google Scholar
• Laccone F, Engel U, Holinski-Feder E, Weigell-Weber M, Marczinek K, Nolte D, et al. DNA analysis of Huntington's disease: five years of experience in Germany, Austria, and Switzerland. Neurology. 1999;53:801–6.
   PubMed Web of Science ®Google Scholar
• Tassicker RJ, Teltscher B, Trembath MK, Collins V, Sheffield LJ, Chiu E, et al. Problems assessing uptake of Huntington disease predictive testing and a proposed solution. Eur J Hum Genet. 2009;17:66–70.
   PubMed Web of Science ®Google Scholar
• Rabkin JPMPH, Goetz RP, Murphy JMP, Factor-Litvak PP. Mitsumoto HMDD, On behalf of the ALSCSG Cognitive impairment, behavioral impairment, depression, and wish to die in an ALS cohort. Neurology. 2016;87:1320–8.
   PubMed Web of Science ®Google Scholar
• van der Meer LB, van Duijn E, Giltay EJ, Tibben A. Do attachment style and emotion regulation strategies indicate distress in predictive testing? J Genet Couns. 2015;24:862–71.
   PubMed Web of Science ®Google Scholar
• Goldman JS. New approaches to genetic counseling and testing for Alzheimer's disease and frontotemporal degeneration. Curr Neurol Neurosci Rep. 2012;12:502–10.
   PubMed Web of Science ®Google Scholar
• Almqvist EW, Bloch M, Brinkman R, Craufurd D, Hayden MR. A Worldwide Assessment of the Frequency of Suicide, Suicide Attempts, or Psychiatric Hospitalization after Predictive Testing for Huntington Disease. Am J Hum Genet. 1999;64:1293–304.
   PubMed Web of Science ®Google Scholar
• Soini S, Ibarreta D, Anastasiadou V, Ayme S, Braga S, Cornel M, et al. The interface between assisted reproductive technologies and genetics: technical, social, ethical and legal issues. Eur J Hum Genet. 2006;14:588–645.
   PubMed Web of Science ®Google Scholar
• Harper JC, Geraedts J, Borry P, Cornel MC, Dondorp W, Gianaroli L, et al. Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy. Eur J Hum Genet. 2013;21:S1–S21.
   PubMed Web of Science ®Google Scholar
• Van Rij MC, De Rademaeker M, Moutou C, Dreesen JC, De Rycke M, Liebaers I, et al. Preimplantation genetic diagnosis (PGD) for Huntington's disease: the experience of three European centres. Eur J Hum Genet. 2012;20:368–75.
   PubMed Web of Science ®Google Scholar
• van Rij MC, de Die-Smulders CEM, Bijlsma EK, de Wert G, Geraedts JP, Roos RAC, et al. Evaluation of exclusion prenatal and exclusion preimplantation genetic diagnosis for Huntington's disease in the Netherlands. Clin Genet. 2013;83:118–24.
   PubMed Web of Science ®Google Scholar
• van Rij MC, de Koning Gans PAM, van Belzen MJ, Roos RAC, Geraedts JPM, De Rademaeker M, et al. The uptake and outcome of prenatal and pre-implantation genetic diagnosis for Huntington's disease in the Netherlands (1998–2008). Clin Genet. 2014;85:87–95.
   PubMed Web of Science ®Google Scholar
• Werner-Lin A, Rubin LR, Doyle M, Stern R, Savin K, Hurley K, et al. “My funky genetics”: BRCA1/2 mutation carriers' understanding of genetic inheritance and reproductive merger in the context of new reprogenetic technologies. Fam Syst Health. 2012;30:166–80.
   PubMed Web of Science ®Google Scholar
• Human Genetics Society of Australasia. Guideline: Process of Genetic Counseling. Australia: Human Genetics Society of Australasia; 2015. Contract No.: 2012GL02.
   Google Scholar
• Harbo HF, Finsterer J, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, et al. EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias.[Erratum appears in Eur J Neurol. 2010 Feb;17(2):339]. Eur J Neurol. 2009;16:777–85.
   PubMed Web of Science ®Google Scholar
• Lattante S, Ciura S, Rouleau GA, Kabashi E. Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD). Trends Genet. 2015;31:263–73.
   PubMed Web of Science ®Google Scholar
• Zufiria M, Gil-Bea FJ, Fernandez-Torron R, Poza JJ, Munoz-Blanco JL, Rojas-Garcia R, et al. ALS: A bucket of genes, environment, metabolism and unknown ingredients. Prog Neurobiol. 2016;142:104–29.
   PubMed Web of Science ®Google Scholar
• Yamashita S, Ando Y. Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis. Transl Neurodegener. 2015;4:13.
   PubMed Web of Science ®Google Scholar
• Williams KL, Topp S, Yang S, Smith B, Fifita JA, Warraich ST, et al. CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nat Commun. 2016;7:11253
   PubMed Web of Science ®Google Scholar
• Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, Muller K, et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci. 2015;18:631–6.
   PubMed Web of Science ®Google Scholar
• Katz JS, Katzberg HD, Woolley SC, Marklund SL, Andersen PM. Combined fulminant frontotemporal dementia and amyotrophic lateral sclerosis associated with an I113T SOD1 mutation. Amyotroph Lateral Scler. 2012;13:567–9.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Nilsson P, Keränen ML, Forsgren L, Hägglund J, Karlsborg M, et al. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain. 1997;120:1723–37.
   PubMed Web of Science ®Google Scholar
• Battistini S, Giannini F, Greco G, Bibbò G, Ferrera L, Marini V, et al. SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study. J Neurol. 2005;252:782–8.
   PubMed Web of Science ®Google Scholar
• Blair IP, Vance C, Durnall JC, Williams KL, Thoeng A, Shaw CE, et al. CHMP2B mutations are not a common cause of familial or sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2008;79:849–50.
   PubMed Web of Science ®Google Scholar
• Vengoechea J, David MP, Yaghi SR, Carpenter L, Rudnicki SA. Clinical variability and female penetrance in X-linked familial FTD/ALS caused by a P506S mutation in UBQLN2. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:615–9.
   PubMed Web of Science ®Google Scholar
• Goldstein O, Nayshool O, Nefussy B, Traynor BJ, Renton AE, Gana-Weisz M, et al. OPTN 691_692insAG is a founder mutation causing recessive ALS and increased risk in heterozygotes. Neurology. 2016;86:446–53.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Nilsson P, Ala-Hurula V, Keranen M-L, Tarvainen I, Haltia T, et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat Genet. 1995;10:61–6.
   PubMed Web of Science ®Google Scholar
• Andersen P, Forsgren L, Binzer M, Nilsson P, Ala-Hurula V, Keränen M-L, et al. Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. Brain. 1996;119:1153–72.
   PubMed Web of Science ®Google Scholar
• Parton MJ, Broom W, Andersen PM, Al-Chalabi A, Leigh PN, Powell JF, et al. D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotype. Hum Mutat. 2002;20:473.
   PubMed Web of Science ®Google Scholar
• Robberecht W, Aguirre T, Van Den Bosch L, Tilkin P, Cassiman JJ, Matthijs G. D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology. 1996;47:1336–9.
   PubMed Web of Science ®Google Scholar
• Williams KL, Fifita JA, Vucic S, Durnall JC, Kiernan MC, Blair IP, et al. Pathophysiological insights into ALS with C9ORF72 expansions. J Neurol Neurosurg Psychiatry. 2013;84:931–5.
   PubMed Web of Science ®Google Scholar
• Devenney E, Hornberger M, Irish M, Mioshi E, Burrell J, Tan R, et al. Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. JAMA Neurol. 2014;71:331–9.
   PubMed Web of Science ®Google Scholar
• Majounie E, Renton AE, Mok K, Dopper EGP, Waite A, Rollinson S, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: A cross-sectional study. Lancet Neurol. 2012;11:323–30.
   PubMed Web of Science ®Google Scholar
• Alavi A, Nafissi S, Rohani M, Shahidi G, Zamani B, Shamshiri H, et al. Repeat expansion in C9ORF72 is not a major cause of amyotrophic lateral sclerosis among Iranian patients. Neurobiol Aging. 2014;35:267.e1.
   PubMed Web of Science ®Google Scholar
• Jang JH, Kwon MJ, Choi WJ, Oh KW, Koh SH, Ki CS, et al. Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2013;34:1311.e7–9.
   Web of Science ®Google Scholar
• Konno T, Shiga A, Tsujino A, Sugai A, Kato T, Kanai K, et al. Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72. J Neurol Neurosurg Psychiatry. 2013;84:398–401.
   PubMed Web of Science ®Google Scholar
• Aguirre T, Matthijs G, Robberecht W, Tilkin P, Cassiman J-J. Mutational analysis of the Cu/Zn superoxide dismutase gene in 23 familial and 69 sporadic cases of amyotrophic lateral sclerosis in Belgium. Eur J Hum Genet. 1999;7:599–602.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Spitsyn VA, Makarov SV, Nilsson L, Kravchuk OI, Bychkovskaya LS, et al. The geographical and ethnic distribution of the D90A CuZn-SOD mutation in the Russian Federation. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2:63–9.
   PubMed Web of Science ®Google Scholar
• Själander A, Beckman G, Deng H-X, Tainer J, Siddique T. The D90A mutation results in a polymorphism of Cu, Zn superoxide dismutase that is prevalent in northern Sweden and Finland. Hum Mol Genet. 1995;4:1105–8.
   PubMed Web of Science ®Google Scholar
• Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1994;124:96–107.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, et al. A revision of the El Escorial criteria-2015. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:291–2.
   PubMed Web of Science ®Google Scholar
• Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–54.
   PubMed Web of Science ®Google Scholar
• Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456–77.
   PubMed Web of Science ®Google Scholar
• Becker F, van El CG, Ibarreta D, Zika E, Hogarth S, Borry P, et al. Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders. Eur J Hum Genet. 2011;19 Suppl 1:S6–S44.
   PubMed Web of Science ®Google Scholar
• Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JBJ, et al. Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol. 2014;13:686–99.
   PubMed Web of Science ®Google Scholar
• Kenna KP, van Doormaal PTC, Dekker AM, Ticozzi N, Kenna BJ, Diekstra FP, et alet al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet 2016;48:1037–42.
   PubMed Web of Science ®Google Scholar
• Valdmanis PN, Rouleau GA. Genetics of familial amyotrophic lateral sclerosis. Neurology. 2008;70:144–52.
   PubMed Web of Science ®Google Scholar
• Chow TW, Miller BL, Hayashi VN, Geschwind DH. Inheritance of frontotemporal dementia. Arch Neurol. 1999;56:817–22.
   PubMed Web of Science ®Google Scholar
• Conte A, Lattante S, Luigetti M, Del Grande A, Romano A, Marcaccio A, et al. Classification of familial amyotrophic lateral sclerosis by family history: effects on frequency of genes mutation. J Neurol Neurosurg Psychiatry. 2012;83:1201–3.
   PubMed Web of Science ®Google Scholar
• Goldman JSMSMCGC, Farmer JMMC, Wood EMM, Johnson JKP, Boxer AMDP, Neuhaus JP, et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology. 2005;65:1817–9.
   PubMed Web of Science ®Google Scholar
• Biank NM, Werner-Lin A. Growing up with Grief: Revisiting the Death of a Parent over the Life Course. Omega (Westport). 2011;63:271–90.
   PubMed Web of Science ®Google Scholar